Paclitaxel, Carboplatin, and G-CSF in Advanced Non-Small-Cell Lung Cancer: A Phase I/II Study

Publisher： Karger

E-ISSN： 2296-5262|21|4|310-314

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.4, 1998-09, pp. : 310-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 333-341

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite

Phase II Trial of Weekly Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 224-228

Karger

Access to resources Recommend Favorite

A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 267-270

Karger

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite